Brainstorm Cell Therapeutics (BCLI) Net Equity Issued and Repurchased (2009 - 2026)
Brainstorm Cell Therapeutics (BCLI) reported Net Equity Issued and Repurchased of $1.02 million for Q2 2026, up 5.5% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Brainstorm Cell Therapeutics' Net Equity Issued and Repurchased came in at $1.99 million, up 32.9% year-over-year; for FY2025, it came in at $1.5 million, down 58.8% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -31.5% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $3.64 million in FY2024 (-48.7%), $7.1 million in FY2023 and $5,000 in FY2021 (-99.9%).
- The Q2 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Brainstorm Cell Therapeutics | 10.92 Mn | 10.85 Mn | - | 1.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 970,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 313,000.00 |
| Jun 30, 2025 | 3.35 Mn |
| Mar 31, 2025 | 2.19 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Jun 30, 2024 | 4.37 Mn |
| Mar 31, 2024 | 2.54 Mn |
| Dec 31, 2023 | 3.35 Mn |
| Sep 30, 2023 | 7.10 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2021 | -34,000.00 |
| Sep 30, 2021 | -106,000.00 |
| Mar 31, 2021 | 7.11 Mn |
| Dec 31, 2020 | 21.06 Mn |
| Sep 30, 2020 | 19.63 Mn |
| Jun 30, 2020 | 7.41 Mn |
| Mar 31, 2020 | 38.92 Mn |
API Access
Brainstorm Cell Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();